all news

Thu, 20 Mar 2025 Business Wire

Podimetrics and Alivi Health Announce New Partnership to Support Diabetic Foot Health

Thu, 20 Mar 2025 GlobeNewswire

PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials

Wed, 19 Mar 2025 GlobeNewswire

FloQast Named “Best Finance Automation Platform” in 2025 FinTech Breakthrough Awards

Sun, 16 Mar 2025 Associated Press

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Fri, 14 Mar 2025 GlobeNewswire

Mass Technology Leadership Council Announces Tech Top 50

Wed, 12 Mar 2025 Associated Press

OM1 Expands into Europe to Strengthen Support for Life Sciences with AI-Driven Real-World Evidence Solutions

Wed, 12 Mar 2025 Associated Press

QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers

Tue, 11 Mar 2025 Associated Press

Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S‑1117, a Novel Pan‑IgG Protease Therapy for Antibody-Mediated Diseases

Tue, 4 Mar 2025 PR Newswire

Ajax Health and KKR Form New Platform to Develop System for Treating Heart Failure

Fri, 28 Feb 2025 Business Wire

Seismic Therapeutic Presents Preclinical Data on S-8484, Its Novel IgE Protease, for Treatment of Allergic Diseases

Tue, 25 Feb 2025 egnyte.com

Egnyte Announces Majority Investment from GI Partners and TA

Mon, 24 Feb 2025 Associated Press

Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia

Wed, 12 Feb 2025 50 States Today

PathAI and Rede D’Or Announce Strategic Partnership to Bring AI-Powered Pathology Solutions to Brazil

Tue, 4 Feb 2025 Associated Press

Auron Therapeutics Announces FDA Clearance to Initiate Clinical Development of AUTX-703 and Completion of Series B Financing

Mon, 3 Feb 2025 TipRanks

Tectonic Therapeutic Secures $185 Million in PIPE Deal

Thu, 30 Jan 2025 GlobeNewswire

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

Wed, 29 Jan 2025 Business Wire

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular At

Wed, 29 Jan 2025 Associated Press

Cohere Health Unveils Cohere Connect™ to Address Prior Authorization Compliance Gaps for Health Plans

Wed, 29 Jan 2025 GlobeNewswire

Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers

Tue, 28 Jan 2025 Business Wire

Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO

Wed, 22 Jan 2025 Associated Press

FloQast Cements Industry Leadership in Ethical, Responsible, and Auditable AI Development with ISO 42001 Certification

Wed, 22 Jan 2025 Global Venturing

Singapore becomes refuge for investors and startups escaping US-China tensions

Wed, 22 Jan 2025 Associated Press

CoV Biotechnology Takes Next Step to Become Leyden Labs Asia

Wed, 15 Jan 2025 Associated Press

Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies

Tue, 14 Jan 2025 Associated Press

Cohere Health Achieves Significant Growth in 2024, Accelerating Momentum as the Leader in AI-Driven Clinical Intelligence

Thu, 9 Jan 2025 Business Wire

Leyden Labs Raises $70M to Advance its Intranasal Antibody Programs to Protect against Influenza and other Viruses

Tue, 7 Jan 2025 Business Wire

FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care

Tue, 7 Jan 2025 Associated Press

BioSpace Names 25 Promising New Biopharma Companies to Watch in 2025

Tue, 17 Dec 2024 Associated Press

Amplifire Named to the 2025 GSV 150: A Top Transformational Growth Company in Digital Learning & Workforce Skills

Thu, 12 Dec 2024 Associated Press

Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership